A recent clinical study of Fast-C, a vitamin C ingredient, has confirmed the ingredient\'s quick absorption and retention rates. The study\'s findings were presented at the American College of Nutrition conference held last week in Orlando, FL.
A recent clinical study of Fast-C, a vitamin C ingredient, has confirmed the ingredient's quick absorption and retention rates. The study's findings were presented at the American College of Nutrition conference held last week in Orlando, FL.
The clinical trial is the second double-blind, randomized crossover clinical trial performed on Fast-C. The first trial took place in 2007 and likewise showed Fast-C's significantly faster vitamin C absorption time and retention.
The newest double-blind, randomized crossover study enrolled 10 nonsmoking male subjects. Results showed a significantly faster rise of vitamin C in the blood following consumption of Fast-C. The ingredient's bioavailability was compared with a leading vitamin C formulation at a 1000-mg single dose. Moreover, despite the faster entry of vitamin C in the blood, retention rates by body tissues were found to be comparatively better based on urinary excretion.
The trial was conducted at Miami Research Associates, a U.S.-based pharmaceutical and nutrition research lab that employs Good Clinical Practices. The lab also conducted the 2007 test on Fast-C.
Patent-pending Fast-C was developed by Scientific Food Solutions. It is distributed by E.T. Horn, in partnership with Alkemy Partners LLC. The ingredient provides a buffered and 90%+ acid-neutralized vitamin C.